Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
07:31aThe Flowr Corporation Joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Validation of Medical Cannabis
GL
07:31aHarrow Health Announces Launch of Mayfield Pharmaceuticals
GL
07:31aCytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions
GL
07:31aStrongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update
GL
07:31aTauriga Sciences Inc. to Integrate QR Codes into Future Product Package Design(s)
GL
07:22aSTRYKER : $272,470 Federal Contract Awarded to Stryker
AQ
07:22aCHARLES RIVER : 2Q Earnings Snapshot
AQ
07:22aHUMANA INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
07:18aARAVIVE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07:16aCANNTRUST : appoints financial advisor for strategic review
PR
07:15aDIASORIN : Board of directors approves first half 2019 results. growth in revenues and profitability
PU
07:13aOMNICELL : Intent to Sole Source to Omnicell, Inc.
AQ
07:13aCHIMERIX INC : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Regulation FD Disclosure (form 8-K)
AQ
07:13aLEXICON PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
07:11aHIGH TIDE : Announces Canna Cabana in Fort Saskatchewan as 11th Location Selling Recreational Cannabis in Alberta
AQ
Discover
08:05aEVOTEC SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
08:05aPAION AG : Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
08:04aALIGN TECHNOLOGY INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
08:04aCatalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019
GL
08:02aBIOTIME : Announces Name Change to Lineage Cell Therapeutics
BU
08:02aForty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
GL
08:01aONCOPEPTIDES : Number of shares and votes in Oncopeptides
AQ
08:01aWELL HEALTH TECHNOLOGIES : to Present at the Canaccord Genuity Growth Conference
AQ
08:01aJOUNCE THERAPEUTICS : to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019
AQ
08:01aINTERCEPT PHARMACEUTICALS : to Announce Second Quarter 2019 Financial Results on August 7, 2019
AQ
08:01aBIOXCEL THERAPEUTICS : to Present at the Canaccord Genuity 2019 Annual Growth Conference
AQ
08:01aKALEIDO BIOSCIENCES : to Present at the 39th Annual Canaccord Genuity Growth Conference
AQ
08:01aLIFEVANTAGE : to Announce Fourth Quarter and Full Fiscal Year 2019 Results on August 14, 2019
AQ
08:01aENDO INTERNATIONAL : Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
PR
08:01aSCYNEXIS, INC. : to Present at the 39th Annual Canaccord Genuity Global Growth Conference
PR
08:01aSelecta Biosciences to Present at Canaccord Genuity's 39th Annual Growth Conference on August 7, 2019
GL
08:01aZynerba Pharmaceuticals to Present at Two Upcoming Conferences
GL
08:01aOncoCyte to Report Second Quarter 2019 Financial Results on Wednesday, August 14, 2019
GL
08:01aAlign Technology Announces $200 Million Accelerated Stock Repurchase Program
GL
07:55aWYETH PAK : Transmission of Quarterly Report for the Period Ended May 31, 2019 of Wyeth Pakistan Limited
AQ
07:51aNAWALOKA HOSPITALS : Kusal Mendis accompanied Avishka to visit his father's condition in the hospital
AQ
07:46aMPX INTERNATIONAL : Featured in a BBC Documentary on Canadian Cannabis Policy
AQ
07:39aTHERMO FISHER SCIENTIFIC : Ontario Institute for Cancer Research - Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing
AQ
07:36aBIOGEN : Alkermes plc - Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis
AQ
07:36aARIDIS PHARMACEUTICALS : Enters Into Equity Purchase and Option Agreements with the Serum Institute of India LTD
AQ
07:36aViiV Healthcare - Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements
AQ
07:36aINVENTIVA : - H1 20191 Financial information and Corporate Business Update
AQ
07:36aMATEON THERAPEUTICS : Oncotelic's Patented Lead Anti-Cancer Drug Candidate as Well as Drug Delivery Platform for Brain Tumors on Track for Advanced Pivotal Phase 3 Clinical Testing
AQ
07:36aALNYLAM PHARMACEUTICALS : and GENESIS Pharma Partner to Commercialize ONPATTRO in South East Europe
AQ
07:36aMOMENTA PHARMACEUTICALS : Announces Fast Track Designation for M281 in Hemolytic Disease of the Fetus and Newborn
AQ
07:36aGLAXOSMITHKLINE : ViiV Healthcare group - Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir
AQ
07:36aINDIVIOR : Reckitt Benckiser Group PLC - FLAT Q2. STRONGER H2 EXPECTED, FULL YEAR NET REVENUE TARGET REVISED
AQ
07:36aEMERGENT BIOSOLUTIONS : Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate
AQ
07:36aChugai Continues to be listed for All ESG Indices Selected by GPIF
AQ
07:35aEISAI : Fatality in Phase I Clinical Study of E2082
AQ
07:35aELI LILLY AND : Lilly's Verzenio Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
AQ
07:35aAYTU BIOSCIENCE : Expands Natesto Partnership with Acerus Pharmaceuticals to Accelerate Natesto Growth in the U.S.
AQ
07:35aAMGEN : Reports Second Quarter 2019 Financial Results
AQ
07:35aALDER BIOPHARMACEUTICALS : to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results
AQ
07:35aOTSUKA : Notice concerning amendments to the forecasts for the first half of FY2019
AQ
07:35aTHERALASE TECHNOLOGIES INC. : - McGill University Health Centre Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
AQ
07:33aCHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
07:33aVACCINEX, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
07:31aTRUTRACE TECHNOLOGIES : The Flowr Corporation Joins Shoppers Drug Mart and TruTrace Technologies Pilot Program for Validation of Medical Cannabis
AQ
07:31aTRULIEVE CANNABIS : Reaches Milestone With 30th Florida Location at Fernandina Beach
AQ
07:31aCANNTRUST : Terminates CEO Amid Unlicensed Cultivation Investigation
AQ
07:31aVaccinex Announces $13.8 Million Private Placement
GL
07:31aSESEN BIO : to Present at the Canaccord Genuity 39th Annual Growth Conference
BU
07:31aVeritas Farms Nationwide Distribution Reaches Over 4,500 Retail Stores
GL
07:31aBIOHAVEN PHARMACEUTICAL : Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
PR
08:13aVENTRIPOINT DIAGNOSTICS : Manufacturing Facility Passed Inspection and First Two VMS+ 3.0 Heart Analysis Machines Shipping to Western Canada
AQ
08:10aMERCK AND : Vaccine Act Dismissal Affirmed—An Intended Component Cannot Be A "Contaminant"
AQ
08:07aSAVARA : to Present at the 39th Annual Canaccord Genuity Global Growth Conference
BU
08:06aRAYSEARCH LABORATORIES PUBL : Ten years ago since first order of RayStation treatment planning system
AQ
08:05aLEXICON : 2Q Earnings Snapshot
AQ
1  2  3  4  5  6  7  8  9  10Next
Advertisement